Medipharm Labs Corp (LABS) - Total Liabilities

Latest as of September 2025: CA$8.74 Million CAD ≈ $6.32 Million USD

Based on the latest financial reports, Medipharm Labs Corp (LABS) has total liabilities worth CA$8.74 Million CAD (≈ $6.32 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Medipharm Labs Corp generate cash to assess how effectively this company generates cash.

Medipharm Labs Corp - Total Liabilities Trend (2016–2024)

This chart illustrates how Medipharm Labs Corp's total liabilities have evolved over time, based on quarterly financial data. Check Medipharm Labs Corp asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Medipharm Labs Corp Competitors by Total Liabilities

The table below lists competitors of Medipharm Labs Corp ranked by their total liabilities.

Company	Country	Total Liabilities
CryoCell International Inc NYSE MKT:CCEL	USA	$78.00 Million
Bflysoft Co. Ltd. KQ:148780	Korea	₩3.93 Billion
ECM Libra Financial Group Bhd KLSE:2143	Malaysia	RM78.99 Million
Blue Star Gold Corp V:BAU	Canada	CA$3.08 Million
Above Food Ingredients Inc. Common Stock NASDAQ:ABVE	USA	$227.56 Million
HydrogenPro AS OL:HYPRO	Norway	Nkr194.34 Million
Verena Multi Finance Tbk JK:VRNA	Indonesia	Rp2.32 Trillion
Investors House HE:INVEST	Finland	€20.00 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Medipharm Labs Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Medipharm Labs Corp (LABS) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.20	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	1.21	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medipharm Labs Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medipharm Labs Corp (2016–2024)

The table below shows the annual total liabilities of Medipharm Labs Corp from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$10.55 Million ≈ $7.63 Million	-3.53%
2023-12-31	CA$10.93 Million ≈ $7.91 Million	+15.19%
2022-12-31	CA$9.49 Million ≈ $6.86 Million	+2.98%
2021-12-31	CA$9.21 Million ≈ $6.67 Million	-76.86%
2020-12-31	CA$39.82 Million ≈ $28.80 Million	+5.89%
2019-12-31	CA$37.60 Million ≈ $27.20 Million	+152.61%
2018-12-31	CA$14.89 Million ≈ $10.77 Million	+489.78%
2017-12-31	CA$2.52 Million ≈ $1.83 Million	+5301.70%
2016-12-31	CA$46.73K ≈ $33.80K	--

About Medipharm Labs Corp

TO:LABS Canada Drug Manufacturers - Specialty & Generic

Market Cap

$27.39 Million

CA$37.87 Million CAD

Market Cap Rank

#24016 Global

#908 in Canada

Share Price

CA$0.09

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.10

All Time High

CA$7.17